메뉴 건너뛰기




Volumn 18, Issue 3, 2008, Pages 107-111

Update on leukaemia

Author keywords

acute lymphoblastic leukaemia; acute myeloid leukaemia; chronic myeloid leukaemia; leukaemia

Indexed keywords

ALPHA INTERFERON; BCR ABL PROTEIN; CYTARABINE; DAUNORUBICIN; FLT3 LIGAND; GEMTUZUMAB OZOGAMICIN; IDARUBICIN; IMATINIB; LESTAURTINIB; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; PROMYELOCYTIC LEUKEMIA PROTEIN; RETINOIC ACID RECEPTOR ALPHA; TIOGUANINE;

EID: 40749107025     PISSN: 17517222     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.paed.2007.12.005     Document Type: Article
Times cited : (3)

References (23)
  • 1
    • 0037541057 scopus 로고    scopus 로고
    • Recent advances in the management of leukaemia
    • Will A. Recent advances in the management of leukaemia. Curr Paediatr 13 (2003) 201-206
    • (2003) Curr Paediatr , vol.13 , pp. 201-206
    • Will, A.1
  • 2
    • 0036042525 scopus 로고    scopus 로고
    • Translation of cure for acute lymphoblastic leukaemia to all children
    • Eden O.B. Translation of cure for acute lymphoblastic leukaemia to all children. Br J Haematol 118 (2002) 945-951
    • (2002) Br J Haematol , vol.118 , pp. 945-951
    • Eden, O.B.1
  • 3
    • 84857938873 scopus 로고    scopus 로고
    • Clinical features and therapy of lymphoblastic leukaemia
    • Arceci R.J., Hann I.M., and Smith O.P. (Eds), Blackwell, Oxford
    • Smith O.P., and Hann I.M. Clinical features and therapy of lymphoblastic leukaemia. In: Arceci R.J., Hann I.M., and Smith O.P. (Eds). Pediatric hematology. 3rd Edn. (2006), Blackwell, Oxford 450-581
    • (2006) Pediatric hematology. 3rd Edn. , pp. 450-581
    • Smith, O.P.1    Hann, I.M.2
  • 4
    • 0035128616 scopus 로고    scopus 로고
    • Practical application of minimal residual disease assessment in childhood acute lymphoblastic leukaemia
    • Goulden N., Oakhill A., and Steward C. Practical application of minimal residual disease assessment in childhood acute lymphoblastic leukaemia. Br J Haematol 112 (2001) 275-281
    • (2001) Br J Haematol , vol.112 , pp. 275-281
    • Goulden, N.1    Oakhill, A.2    Steward, C.3
  • 5
    • 0032576355 scopus 로고    scopus 로고
    • Prognostic value of MRD in ALL in children
    • van Dongen J.J., Seriu T., Payer-Grumayer E.R., et al. Prognostic value of MRD in ALL in children. Lancet 352 (1998) 1731-1738
    • (1998) Lancet , vol.352 , pp. 1731-1738
    • van Dongen, J.J.1    Seriu, T.2    Payer-Grumayer, E.R.3
  • 6
    • 0034525991 scopus 로고    scopus 로고
    • Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997
    • Eden O.B., Harrison G., Richards S., et al. Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Leukaemia 12 (2000) 2307-2320
    • (2000) Leukaemia , vol.12 , pp. 2307-2320
    • Eden, O.B.1    Harrison, G.2    Richards, S.3
  • 7
    • 34447519040 scopus 로고    scopus 로고
    • 'Interfant 06'-novel protocol increases survival in infants with acute lymphoblastic leukaemia
    • Pieters R., Schrappe M., De Cronig P., et al. 'Interfant 06'-novel protocol increases survival in infants with acute lymphoblastic leukaemia. Lancet 370 (2007) 240-250
    • (2007) Lancet , vol.370 , pp. 240-250
    • Pieters, R.1    Schrappe, M.2    De Cronig, P.3
  • 8
    • 0032572912 scopus 로고    scopus 로고
    • Acute lymphoblastic leukaemia
    • Pui C.-H., and Evans W.E. Acute lymphoblastic leukaemia. N Engl J Med 339 (1998) 606-615
    • (1998) N Engl J Med , vol.339 , pp. 606-615
    • Pui, C.-H.1    Evans, W.E.2
  • 9
    • 0034611661 scopus 로고    scopus 로고
    • Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukaemia
    • Arico M., Valsecchi M.C., Camitta B., et al. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukaemia. N Engl J Med 342 (2000) 998-1006
    • (2000) N Engl J Med , vol.342 , pp. 998-1006
    • Arico, M.1    Valsecchi, M.C.2    Camitta, B.3
  • 10
    • 0032532289 scopus 로고    scopus 로고
    • Philadelphia chromosome-positive childhood acute lymphoblastic leukaemia: good initial steroid response allows early prediction of a favourable treatment outcome
    • Scrappe M., Arico M., Harbott J., et al. Philadelphia chromosome-positive childhood acute lymphoblastic leukaemia: good initial steroid response allows early prediction of a favourable treatment outcome. Blood 92 (1998) 2730-2741
    • (1998) Blood , vol.92 , pp. 2730-2741
    • Scrappe, M.1    Arico, M.2    Harbott, J.3
  • 11
    • 0033585485 scopus 로고    scopus 로고
    • A BCR/ABL kinase antagonist for CML: a promising path for progress emerges
    • Sausville E.A. A BCR/ABL kinase antagonist for CML: a promising path for progress emerges. J Natl Cancer Inst 91 (1999) 102-103
    • (1999) J Natl Cancer Inst , vol.91 , pp. 102-103
    • Sausville, E.A.1
  • 12
    • 0037105560 scopus 로고    scopus 로고
    • Results of a phase II study to determine the safety and anti-leukaemic effects of imatinib in adults with Philadelphia positive leukaemia
    • Ottmann O.G., Druker B., Sawyers C., et al. Results of a phase II study to determine the safety and anti-leukaemic effects of imatinib in adults with Philadelphia positive leukaemia. Blood 100 (2002) 1965-1971
    • (2002) Blood , vol.100 , pp. 1965-1971
    • Ottmann, O.G.1    Druker, B.2    Sawyers, C.3
  • 13
    • 0027941369 scopus 로고
    • Intensive post remission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B
    • Mayer R.J., Davis R.B., Schiffer C.A., et al. Intensive post remission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. N Engl J Med 331 (1994) 896-903
    • (1994) N Engl J Med , vol.331 , pp. 896-903
    • Mayer, R.J.1    Davis, R.B.2    Schiffer, C.A.3
  • 14
    • 0035397980 scopus 로고    scopus 로고
    • Efficacy and safety of Gemtuzumab in patients with CD33-positive acute myeloid leukemia in first relapse
    • Sievers E.L., Larson Rarjian A., Stadtmauer E.A., et al. Efficacy and safety of Gemtuzumab in patients with CD33-positive acute myeloid leukemia in first relapse. J Clin Oncol 19 (2001) 3244-3254
    • (2001) J Clin Oncol , vol.19 , pp. 3244-3254
    • Sievers, E.L.1    Larson Rarjian, A.2    Stadtmauer, E.A.3
  • 15
    • 34249775270 scopus 로고    scopus 로고
    • The addition of gemtuzumab ozogamicin to induction chemotherapy for AML improves disease free survival without extra toxicity: preliminary analysis of 1115 patients in the MRC15 trial
    • (abstract 13)
    • Burnett A.K., Kell W.J., Goldstone A.H., et al. The addition of gemtuzumab ozogamicin to induction chemotherapy for AML improves disease free survival without extra toxicity: preliminary analysis of 1115 patients in the MRC15 trial. Blood 108 (2007) 8a (abstract 13)
    • (2007) Blood , vol.108
    • Burnett, A.K.1    Kell, W.J.2    Goldstone, A.H.3
  • 16
    • 0037097716 scopus 로고    scopus 로고
    • Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukaemia: association with FAB subtypes and identification of subgroups with a poor prognosis
    • Theide C., Steudel C., Mohr B., et al. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukaemia: association with FAB subtypes and identification of subgroups with a poor prognosis. Blood 99 (2002) 4326-4335
    • (2002) Blood , vol.99 , pp. 4326-4335
    • Theide, C.1    Steudel, C.2    Mohr, B.3
  • 17
    • 33751180608 scopus 로고    scopus 로고
    • A phase II trial of the FLT-3 inhibitor CEP-701 as first line treatment for older patients with AML not considered fit for intensive chemotherapy
    • Knapper S., Burnett A.K., Kell J., et al. A phase II trial of the FLT-3 inhibitor CEP-701 as first line treatment for older patients with AML not considered fit for intensive chemotherapy. Blood 104 (2004) 246a-247a
    • (2004) Blood , vol.104
    • Knapper, S.1    Burnett, A.K.2    Kell, J.3
  • 18
    • 18544375333 scopus 로고    scopus 로고
    • MLL gene translocations specify a distinct gene expression profile that distinguishes a unique leukaemia
    • Armstrong S.A., Staunton J.E., Silverman L.B., et al. MLL gene translocations specify a distinct gene expression profile that distinguishes a unique leukaemia. Nat Genet 30 (2002) 41-47
    • (2002) Nat Genet , vol.30 , pp. 41-47
    • Armstrong, S.A.1    Staunton, J.E.2    Silverman, L.B.3
  • 19
    • 0033230342 scopus 로고    scopus 로고
    • A modified AIDA protocol with anthracycline-based consolidation results in high anti-leukaemia efficacy and reduced toxicity in newly diagnosed/RAR positive APML
    • Sanz M., Martin E., Rayon L., et al. A modified AIDA protocol with anthracycline-based consolidation results in high anti-leukaemia efficacy and reduced toxicity in newly diagnosed/RAR positive APML. Blood 94 (1999) 3015-3021
    • (1999) Blood , vol.94 , pp. 3015-3021
    • Sanz, M.1    Martin, E.2    Rayon, L.3
  • 20
    • 0035884639 scopus 로고    scopus 로고
    • United States multicentre study of arsenic trioxide in relapsed acute promyelocytic leukaemia
    • Soignet S.L., Frankel S.R., Douer D., et al. United States multicentre study of arsenic trioxide in relapsed acute promyelocytic leukaemia. J Clin Oncol 19 (2001) 3852-3860
    • (2001) J Clin Oncol , vol.19 , pp. 3852-3860
    • Soignet, S.L.1    Frankel, S.R.2    Douer, D.3
  • 21
    • 0142058034 scopus 로고    scopus 로고
    • Down's syndrome and acute myeloid leukaemia: the paradox of increased risk and heightened sensitivity to chemotherapy-an editorial
    • Ravindranath Y. Down's syndrome and acute myeloid leukaemia: the paradox of increased risk and heightened sensitivity to chemotherapy-an editorial. J Clin Oncol 212 (2003) 3385-3387
    • (2003) J Clin Oncol , vol.212 , pp. 3385-3387
    • Ravindranath, Y.1
  • 22
    • 76449091767 scopus 로고    scopus 로고
    • Relapsed acute myeloid leukaemia in children and adolescents: interim report of the international randomised phase III study Relapsed AML 2001/01
    • abstract 2013
    • Kaspers G.J., Zimmermann M., Fleischhack G., et al. Relapsed acute myeloid leukaemia in children and adolescents: interim report of the international randomised phase III study Relapsed AML 2001/01. Blood 108 (2007) 570a abstract 2013
    • (2007) Blood , vol.108
    • Kaspers, G.J.1    Zimmermann, M.2    Fleischhack, G.3
  • 23
    • 0041737629 scopus 로고    scopus 로고
    • Stem cell transplantation for chronic myeloid leukaemia in children
    • Cwynarski K., Roberts I.A.G., Iacobelli S., et al. Stem cell transplantation for chronic myeloid leukaemia in children. Blood 102 (2003) 1224-1231
    • (2003) Blood , vol.102 , pp. 1224-1231
    • Cwynarski, K.1    Roberts, I.A.G.2    Iacobelli, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.